Neurotechnology company formerly Blackrock Microsystems, developing Utah/NeuroPort recording systems and the MoveAgain BCI. Tether became majority stakeholder in April 2024; the $200M control transaction is distinct from ordinary financing.
Founded 2008
team@apexlogos.ai · yesterday
team@apexlogos.ai · 2 days ago
BCI research snapshot, reviewed 2026-10-06. Company identity: BlackrockNeurotech. This is the pre-import evidence dossier; historical statements about database absence or review are archival. Unverified claims remain research leads, not validated facts.
Part 1/1
# Blackrock Neurotech
Research date: **2026-10-06**. Review material only; no adex data was modified. All linked sources and HTML image references were accessed on this date.
## Identity and operating status
**Blackrock Neurotech**, privately held neurotechnology company founded **2008**, based in **Salt Lake City, Utah**. Formerly branded Blackrock Microsystems; it adopted Blackrock Neurotech in May 2021 while maintaining research-brand continuity. Exact current registered suffix should be checked before legal-entity import. [Company financing/rebrand release](https://blackrockneurotech.com/insights/blackrock-neurotech-closes-10m-financing-round-to-advance-development-of-its-world-leading-brain-computer-interface-bci-technology/ )
Implanted Utah/NeuroPort arrays and recording systems support research and human BCI work. **MoveAgain** is the clinical BCI program. Its 2021 FDA Breakthrough Device designation must not be mislabeled full commercial approval. [Official MoveAgain announcement](https://blackrockneurotech.com/insights/blackrock-neurotechs-moveagain-brain-computer-interface-system-receives-breakthrough-device-designation-from-the-fda/ ) Not related to BlackRock the asset manager.
## Audit of pasted BCI.INTEL entry
| Pasted claim | Assessment |
|---|---|
| Salt Lake City; Marcus Gerhardt CEO | Supported by official company/leadership releases. |
| $250M+ total | Not reconciled from primary rounds reviewed ($10M and $200M strategic transaction). Hold aggregate. |
| Utah array / MoveAgain | Genuine product/platform names; preserve research-vs-clinical distinction. |
| ACTIVE | Operating brand supported; **Tether became majority stakeholder in April 2024**, so ownership status should be recorded. |
| Ticker 40 implants | Implant tally needs its own date/definition; not validated as an evergreen count. |
## Company profile image
Official logo/brand artwork could not be confidently isolated from raw HTML because server returned HTTP 406. Save [official website](https://blackrockneurotech.com/ ) and [official team page](https://blackrockneurotech.com/team/ ) as source; **company image direct URL unavailable**, pending asset inspection. Current headshots are direct official PNG URLs, listed above; decorative “highlighted particle” image was excluded as not a company logo.
## Founders and public team
| Person | Role / relationship | Profile and role evidence | Direct profile image URL |
|---|---|---|---|
| Marcus Gerhardt | Current CEO; co-founder | [Official team](https://blackrockneurotech.com/team/ ) | [PFP](https://blackrockneurotech.com/wp-content/uploads/2023/01/Marcus-Gerhardt.png ) |
| Florian Solzbacher | Co-founder and Chairman | [Official team](https://blackrockneurotech.com/team/ ) | [PFP](https://blackrockneurotech.com/wp-content/uploads/2023/01/Florian_Solzbacher.png ) |
| Christian Angermayer | Director / investor; not founder inferred | [Official team](https://blackrockneurotech.com/team/ ) | [PFP](https://blackrockneurotech.com/wp-content/uploads/2023/01/Christian-Angermayer.png ) |
Official team page also shows a senior finance executive described as “Thomas” who joined in 2024 and sales/support personnel. Retrieved page text does not establish his full name; do not manufacture a Person ID or match it to an unrelated Thomas. Image available for later review: [Finance card image](https://blackrockneurotech.com/wp-content/uploads/IMG_0470-2-scaled.png ). Team image URLs were resolved via official page image links. Local raw fetch returned HTTP 406, while browser research retrieved the page and linked images.
## Investments and financing
| Date | Type | Amount (USD) | Lead | Other named investors | Evidence |
|---|---|---:|---|---|---|
| 2021-05-19 | Institutional equity financing, no letter stage asserted | $10M | re.Mind Capital | Peter Thiel; Tim Sievers; Sorenson Impact University Venture Fund II | [Official company financing release](https://blackrockneurotech.com/insights/blackrock-neurotech-closes-10m-financing-round-to-advance-development-of-its-world-leading-brain-computer-interface-bci-technology/ ) |
| 2024-04-29 | Strategic investment / majority control | $200M | Tether / Tether Evo | No other investors named | [Official company announcement](https://blackrockneurotech.com/insights/tether-invested-200m-in-blackrock-neurotech-accelerating-development-and-commercialization-of-implantable-bci-technology/ ) |
Historical investor announcement is still linked from [Tether’s public announcement channel](https://t.me/s/tether?before=363 ), but its original webpage now returns404; company announcement above remains the substantive source. The $200M transaction made Tether majority owner; the sources do not fully distinguish primary capital from any secondary share purchases. **Do not automatically classify the entire amount as a standard equity funding round.** Prior friends/family backing and operating revenue are acknowledged in the 2021 release without an amount. No verified corporate debt/grant close is recorded. University clinical research grants are not automatically financing received by Blackrock.
## Existing adex match and review decision
Already present as `BlackrockNeurotech`. Enrich after review and separate Tether majority ownership from financing. Do not match `BlackRock` investment firm. The $250M+ total and implant count require further reconciliation before import.
Read-only `Org` lookup found the following records. The snapshot below records existing claims, **not verification of those claims**. SHOW MORE
team@apexlogos.ai · 23 days ago
COMPETITION 
Anthony KhongProduct and Support Manager
Christian AngermayerDirector
Dorette FickInside Sales Representative
Florian SolzbacherCo-founder and Chairman
Greg PalisDirector, Sales and Support
Manya MuraliSupport Engineer
Mitchell RileySupport Engineer
Nivas Asok KumarNeuroscience Applications Engineer
Shuai WangSales Operations Manager
Thomas ThieleChief Financial Officer
Tim SieversCo-Chairman